David M. Flavell

1.8k total citations
25 papers, 1.5k citations indexed

About

David M. Flavell is a scholar working on Molecular Biology, Physiology and Cell Biology. According to data from OpenAlex, David M. Flavell has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Cell Biology. Recurrent topics in David M. Flavell's work include Peroxisome Proliferator-Activated Receptors (10 papers), Adipose Tissue and Metabolism (8 papers) and Metabolism, Diabetes, and Cancer (4 papers). David M. Flavell is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (10 papers), Adipose Tissue and Metabolism (8 papers) and Metabolism, Diabetes, and Cancer (4 papers). David M. Flavell collaborates with scholars based in United Kingdom, France and Finland. David M. Flavell's co-authors include Jean‐Pierre Julien, Frank Grosveld, Bart Staels, Steve E. Humphries, Inès Pineda‐Torra, Yalda Jamshidi, J. Hurst, Walter E. Mushynski, Hugh Montgomery and Philippa J. Talmud and has published in prestigious journals such as Nucleic Acids Research, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Flavell

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Flavell United Kingdom	18	848	336	328	304	226	25	1.5k
Susan Gray United States	19	1.4k 1.7×	427 1.3×	306 0.9×	213 0.7×	127 0.6×	21	2.1k
Sucheta M. Vaingankar United States	19	798 0.9×	172 0.5×	230 0.7×	295 1.0×	109 0.5×	41	1.6k
Raymonde Bredoux France	28	1.2k 1.5×	157 0.5×	172 0.5×	434 1.4×	306 1.4×	55	2.0k
Frédéric Leprêtre France	21	690 0.8×	460 1.4×	405 1.2×	107 0.4×	164 0.7×	47	1.8k
Shaw‐Yung Shai United States	22	804 0.9×	238 0.7×	203 0.6×	104 0.3×	506 2.2×	28	1.8k
Nathalie Danièle France	18	742 0.9×	215 0.6×	136 0.4×	159 0.5×	139 0.6×	27	1.1k
Anne Crozat United States	17	1.3k 1.5×	102 0.3×	155 0.5×	269 0.9×	144 0.6×	24	1.9k
Linda Robinson United States	17	802 0.9×	242 0.7×	100 0.3×	296 1.0×	148 0.7×	24	1.4k
John H. Chidlow United States	14	453 0.5×	233 0.7×	131 0.4×	256 0.8×	138 0.6×	15	1.1k
Shian-Huey Chiang United States	15	1.1k 1.3×	721 2.1×	160 0.5×	392 1.3×	163 0.7×	15	2.1k

Countries citing papers authored by David M. Flavell

Since Specialization

Citations

This map shows the geographic impact of David M. Flavell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Flavell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Flavell more than expected).

Fields of papers citing papers by David M. Flavell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Flavell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Flavell. The network helps show where David M. Flavell may publish in the future.

Co-authorship network of co-authors of David M. Flavell

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Flavell. A scholar is included among the top collaborators of David M. Flavell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Flavell. David M. Flavell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giansanti, Francesco, et al.. (2013). Dissecting the Entry Route of Saporin-based a-CD7 Immunotoxins in Human T-Cell Acute Lymphoblastic Leukaemia Cells. SHILAP Revista de lepidopterología. 2(1). 50–65. 1 indexed citations

Flavell, David M., et al.. (2007). IP receptor-dependent activation of PPARγ by stable prostacyclin analogues. Biochemical and Biophysical Research Communications. 360(4). 821–827. 54 indexed citations

Talmud, Philippa J., David M. Flavell, Khaled Alfakih, et al.. (2007). The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease. Clinical Science. 112(12). 617–624. 11 indexed citations

Ahmetov, Ildus I., David M. Flavell, Irina V. Astratenkova, et al.. (2006). PPARα gene variation and physical performance in Russian athletes. European Journal of Applied Physiology. 97(1). 103–108. 86 indexed citations

Flavell, David M., Saul Myerson, Michael World, et al.. (2006). Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth. Journal of Molecular Medicine. 84(2). 126–131. 6 indexed citations

Flavell, David M., et al.. (2006). Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training. Nutrition Metabolism and Cardiovascular Diseases. 17(1). 24–31. 17 indexed citations

Putt, W., Jutta Palmen, Viviane Nicaud, et al.. (2004). Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Human Molecular Genetics. 13(15). 1587–1597. 74 indexed citations

Foucher, Christelle, David M. Flavell, Philippa J. Talmud, et al.. (2004). Response to micronized fenofibrate treatment is associated with the peroxisome???proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes. Pharmacogenetics. 14(12). 823–829. 43 indexed citations

Elrayess, Mohamed A., Karen E. Webb, David M. Flavell, et al.. (2003). A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies. Atherosclerosis. 168(1). 131–138. 31 indexed citations

10.

Wells, Sara, David M. Flavell, G. W. Bisset, et al.. (2003). Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones. The Journal of Physiology. 551(1). 323–336. 11 indexed citations

11.

Talmud, Philippa J., Steve Martin, George Steiner, et al.. (2003). Progression of Atherosclerosis Is Associated With Variation in the α ₁ -Antitrypsin Gene. Arteriosclerosis Thrombosis and Vascular Biology. 23(4). 644–649. 58 indexed citations

12.

Doney, Alex S. F., Bettina Fischer, Alastair M. Cumming, et al.. (2002). Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genetics. 3(1). 21–21. 108 indexed citations

13.

Pineda‐Torra, Inès, Yalda Jamshidi, David M. Flavell, Jean‐Charles Fruchart, & Bart Staels. (2002). Characterization of the Human PPARα Promoter: Identification of a Functional Nuclear Receptor Response Element. Molecular Endocrinology. 16(5). 1013–1028. 142 indexed citations

14.

Eurlings, Petra M.H., Carla Kallen, Jan M.W. Geurts, David M. Flavell, & Tjerk W.A. de Bruin. (2002). Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia. Molecular Genetics and Metabolism. 77(4). 274–281. 16 indexed citations

15.

Jamshidi, Yalda, Hugh Montgomery, Hans‐Werner Hense, et al.. (2002). Peroxisome Proliferator–Activated Receptor α Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension. Circulation. 105(8). 950–955. 124 indexed citations

16.

Wells, Timothy, David M. Flavell, Sara Wells, Danielle Carmignac, & Iain C. A. F. Robinson. (1997). Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat. Endocrinology. 138(2). 580–587. 28 indexed citations

17.

Carmignac, Danielle, David M. Flavell, & Iain C.A.F. Robinson. (1996). Pituitary Growth Hormone-Releasing Factor Receptor Expression in Normal and Dwarf Rats. Neuroendocrinology. 64(3). 177–185. 19 indexed citations

18.

Ackrill, Andrew M., Graham R. Foster, Carl Laxton, et al.. (1991). Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Research. 19(16). 4387–4393. 105 indexed citations

19.

Julien, Jean‐Pierre, Francine Côté, Lucille Beaudet, et al.. (1988). Sequence and structure of the mouse gene coding for the largest neurofilament subunit. Gene. 68(2). 307–314. 90 indexed citations

20.

Julien, Jean‐Pierre, et al.. (1987). The structure of a human neurofilament gene (NF-L): A unique exon-intron organization in the intermediate filament gene family. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 909(1). 10–20. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact